发明名称 CYCLIC GLYCYL-2-ALLYL PROLINE IMPROVES COGNITIVE PERFORMANCE IN IMPAIRED ANIMALS
摘要 Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat symptoms of cognitive impairment associated with developmental disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such conditions.
申请公布号 US2015258091(A1) 申请公布日期 2015.09.17
申请号 US201514725096 申请日期 2015.05.29
申请人 Neuren Pharmaceuticals Limited 发明人 Bickerdike Michael John;Guan Jian
分类号 A61K31/4985 主分类号 A61K31/4985
代理机构 代理人
主权项 1. A method for treating a symptom of cognitive impairment in a mammal in need thereof, comprising: administering a pharmaceutically effective amount of cyclic Glycyl-2-Allyl Proline (cG-2-AllylP) to said mammal, said cognitive impairment resulting from a developmental disorder.
地址 Auckland NZ